Peptide F9

Discontinued product

Unfortunately Peptide F9 (Cat. No. 1903) was withdrawn from sale in Aug. 2014 for commercial reasons.

To view previous batch information for Peptide F9 (Cat. No. 1903) please follow the links below:

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

View Related Products by Target

Keywords: inhibitors inhibits laminin-mediated cell adhesion migration Adhesion Molecules heparin PeptideF9

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Life Science Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance. Request copy today.

divider line

LinkedIn Updates

Follow Tocris on LinkedIn

Follow us on LinkedIn!

Visit our LinkedIn page for the latest Tocris news, events and updates.